The novel antidepressant ketamine enhances dentate gyrus proliferation with no effects on synaptic plasticity or hippocampal function in depressive‐like rats
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Aim: Major depressive disorder is a common and debilitating condition with substantial economic impact. Treatment options, although effective, are aimed at relieving the symptoms with limited disease modification. Ketamine, a commonly used anaesthetic, has received substantial attention as it shows rapid antidepressant effects clinically. We studied the effects of ketamine on hippocampal function and dentate gyrus proliferation in rats showing a depressive‐like phenotype. Methods: Adolescent and adult animals were pre‐natally exposed to the glucocorticoid analog dexamethasone, and we verified a depressive‐like phenotype using behavioural tests, such as the sucrose preference. We subsequently studied the effects of ketamine on hippocampal synaptic transmission, plasticity and dentate gyrus proliferation. In addition, we measured hippocampal glutamate receptor expression. We also tested the ketamine metabolite hydroxynorketamine for NMDA‐receptor independent effects. Results: Surprisingly, our extensive experimental survey revealed limited effects of ketamine or its metabolite on hippocampal function in control as well as depressive‐like animals. We found no effects on synaptic efficacy or induction of long‐term potentiation in adolescent and adult animals. Also there was no difference when comparing the dorsal and ventral hippocampus. Importantly, however, ketamine 24 hours prior to experimentation significantly increased the dentate gyrus proliferation, as revealed by Ki‐67 immunostaining, in the depressive‐like phenotype. Conclusion: We find limited effects of ketamine on hippocampal glutamatergic transmission. Instead, alterations in dentate gyrus proliferation could explain the antidepressant effects of ketamine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evidence-based health policy—lessons from the Global Burden of Disease Study
Murray, C. J. L., & Lopez, A. D. (1996) · Science · doi:10.1126/science.274.5288.740 · Cited by 2,178
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926 · cited 4×
“An increased efficacy of glutamatergic synaptic transmission is thought to involve BDNF and mammalian target of rapamycin (mTOR)‐mediated increase in synapses(77) or a post‐synaptic up‐regulation of AMPAR.(17) The increase in BDNF and mTOR is in itself AMPAR‐dependent.”
BackgroundResultInfluentialMoghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793
Functional organization of the hippocampal longitudinal axis
Strange, B. A., Witter, M. P., Lein, E. S., & Moser, E. I. (2014) · Nature reviews. Neuroscience · doi:10.1038/nrn3785 · Cited by 1,738
Global burden of depressive disorders in the year 2000
Üstün, T. B., Ayuso-Mateos, J. L., Chatterji, S., Mathers, C., & Murray, C. J. L. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.5.386 · Cited by 1,735 · cited 1×
“It is also the fourth leading cause of disease burden world‐wide due to prevalence, age of onset and chronicity.(2,3) The reported prevalence of depressive episodes throughout the world is 16 per 100 000 per year for males and 25 per 100 000 per year for females.”
BackgroundGlutamate receptor dysfunction and schizophrenia
Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Zanos, P., Moaddel, R., Morris, P. J., Georgiou, P., Fischell, J., Elmer, G. I., Alkondon, M., Yuan, P., Pribut, H. J., Singh, N. S., et al. (2016) · Nature · doi:10.1038/nature17998 · Cited by 1,609
Hippocampal volume and depression: a meta-analysis of MRI studies
Videbech, P., & Ravnkilde, B. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.1957 · Cited by 1,590
Ketamine—its pharmacology and therapeutic uses
white, P. F., Way, W. L., & Trevor, A. J. (1982) · Anesthesiology · doi:10.1097/00000542-198202000-00007 · Cited by 1,474
Adult hippocampal neurogenesis in depression
Sahay, A., & Hen, R. (2007) · Nature Neuroscience · doi:10.1038/nn1969 · Cited by 1,206 · cited 1×
“Nevertheless an altered dentate gyrus neurogenesis has been linked to depressive states.(56,94) In line with our results, ketamine(90) as well as other classical antidepressants such as imipramine and fluoxetine(95) or agomelatine(96) increase or normalize dentate gyrus proliferation and neurogenesis, which could be e…”
ResultChronic mild stress-induced anhedonia: A realistic animal model of depression
Willner, P., Muscat, R., & Papp, M. (1992) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80194-0 · Cited by 1,160 · cited 1×
“These effects were rapid, but similar albeit slower responses have been seen with traditional antidepressants in models of chronic mild stress.(62) We observed no detectable sex differences or overall fluid intake in any of the measured variables or treatments (data not shown).”
ResultLower Hippocampal Volume in Patients Suffering From Depression: A Meta-Analysis
Campbell, S., Marriott, M., Nahmias, C., & MacQueen, G. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.4.598 · Cited by 1,156
Maeng, S., Zarate, C. A., Du, J., Schloesser, R. J., McCammon, J., Chen, G., & Manji, H. K. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.028 · Cited by 1,103
Ketamine blocks bursting in the lateral habenula to rapidly relieve depression
Yang, Y., Cui, Y., Sang, K., Dong, Y., Ni, Z., Ma, S., & Hu, H. (2018) · Nature · doi:10.1038/nature25509 · Cited by 1,036
Using the rat forced swim test to assess antidepressant-like activity in rodents
Slattery, D. A., & Cryan, J. F. (2012) · Nature Protocols · doi:10.1038/nprot.2012.044 · Cited by 903 · cited 3×
“Similarly, longer animals can reach the bottom of the cylinder with the tails, altering behaviour and locomotor activity.(59,64)”
BackgroundMethodPrevalence and clinical course of depression: a review
Richards, D. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2011.07.004 · Cited by 623
Signaling pathways underlying the rapid antidepressant actions of ketamine
Duman, R. S., Li, N., Liu, R.-J., Duric, V., & Aghajanian, G. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.044 · Cited by 537 · cited 2×
“Ketamine might thus eliminate depressive symptoms by restoring the number of synapses and subsequent glutamatergic signalling in the hippocampus and the pre‐frontal cortex.(24,25) Impact on network signalling and oscillations within the hippocampus is at present unknown, but there are indications that ketamine has a d…”
BackgroundMethodLucassen, P. J., Meerlo, P., Naylor, A. S., van Dam, A. M., Dayer, A. G., Fuchs, E., Oomen, C. A., & Czéh, B. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.08.003 · Cited by 449
Takei, N., Inamura, N., Kawamura, M., Namba, H., Hara, K., Yonezawa, K., & Nawa, H. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1427-04.2004 · Cited by 442
Postnatal synaptic potentiation: delivery of GluR4-containing AMPA receptors by spontaneous activity
Zhu, J. J., Esteban, J. A., Hayashi, Y., & Malinow, R. (2000) · Nature Neuroscience · doi:10.1038/80614 · Cited by 437
Feyissa, A. M., Chandran, A., Stockmeier, C. A., & Karolewicz, B. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.10.005 · Cited by 421 · cited 1×
“There is also decreased expression of GluN2B in the hippocampus but not in the prefrontal cortex, in animals pre‐natally exposed to dexamethasone,(66) as well as clinically in port‐mortem tissue from patients with major depression.(84) This is opposite to Tsai et al(85) showing instead an increased expression, but onl…”
BackgroundZhou, W., Wang, N., Yang, C., Li, X.-M., Zhou, Z.-Q., & Yang, J.-J. (2014) · European Psychiatry · doi:10.1016/j.eurpsy.2013.10.005 · Cited by 390 · cited 2×
“transmission.(7,19,20) We find, however, no evidence for such ketamine‐induced increase in AMPAR mediated transmission in any of our experimental protocols.”
BackgroundMiller, O. H., Yang, L., Wang, C.-C., Hargroder, E. A., Zhang, Y., Delpire, E., & Hall, B. J. (2014) · eLife · doi:10.7554/elife.03581 · Cited by 358 · cited 3×
“Widman et al73 show that low doses of ketamine have a preferential role on interneurons, similar to previous results by Miller et al.16 An altered balance of inhibition and excitation by ketamine should impact network signalling and oscillatory patterns within the hippocampus, leading to overall effects on, for exampl…”
BackgroundResultR (−)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine
Zhang, J.-C., Li, S.-X., & Hashimoto, K. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.11.033 · Cited by 357
Agomelatine, a new antidepressant, induces regional changes in hippocampal neurogenesis
Banasr, M., Soumier, A., Hery, M., Mocaër, E., & Daszuta, A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.025 · Cited by 318
Sanacora, G., Smith, M. A., Pathak, S., Su, H.-L., Boeijinga, P. H., McCarthy, D. J., & Quirk, M. C. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.130 · Cited by 236
Gideons, E. S., Kavalali, E. T., & Monteggia, L. M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323920111 · Cited by 232 · cited 6×
“Despite their difference in NMDAR desensitization,(105) memantine is also potentially antidepressant.(19) However, such specificity might, at least partly, explain the antidepressant actions of ketamine with more limited(106) effects of other open‐channel blockers such as MK‐801.”
BackgroundMethodResultInfluentialWidman, A. J., & McMahon, L. L. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718883115 · Cited by 204
Miller, O. H., Moran, J. T., & Hall, B. J. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.07.028 · Cited by 200 · cited 2×
“However, this is in contrast to studies showing no specific effect of ketamine on fast spiking, parvalbumin‐containing interneurons.(27,28) There are also conflicting results regarding ketamine causing a hyperglutamatergic state(29) or rather a pre‐synaptic NR2B‐dependant decrease in release probability.”
ResultMoaddel, R., Abdrakhmanova, G., Kozak, J., Jozwiak, K., Toll, L., Jimenez, L., Rosenberg, A., Tran, T., Xiao, Y., Zarate, C. A., et al. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.11.023 · Cited by 176
Donahue, R. J., Muschamp, J. W., Russo, S. J., Nestler, E. J., & Carlezon, W. A. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.12.014 · Cited by 161 · cited 1×
“This is similar to the effects of ketamine on anhedonic‐like behaviour after social defeat stress.(61) Another NMDAR receptor blocker, MK801, also restores sucrose preference in a pre‐natal stress model when administered before the stressor.”
ResultDorsal vs Ventral Hippocampal Neurogenesis: Implications for Cognition and Mood
Kheirbek, M. A., & Hen, R. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.148 · Cited by 140
Ketamine Disrupts Theta Modulation of Gamma in a Computer Model of Hippocampus
Neymotin, S. A., Lazarewicz, M. T., Sherif, M., Contreras, D., Finkel, L. H., & Lytton, W. W. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.0501-11.2011 · Cited by 139 · cited 2×
“Impact on network signalling and oscillations within the hippocampus is at present unknown, but there are indications that ketamine has a differential effect on excitatory pyramidal cells and inhibitory interneurons,(16) potentially affecting the balance of inhibition and excitation and oscillatory activity.(26) Howev…”
MethodResultIafrati, J., Orejarena, M. J., Lassalle, O., Bouamrane, L., & Chavis, P. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.66 · Cited by 132 · cited 3×
“Importantly, not all open‐channel blockers of the NMDA‐receptor have the same efficacy when considering the antidepressive properties.(13,15,17,19) This is conceivably explained by differential effects on, for example, NMDA‐ receptor desensitization when comparing ketamine and memantine.”
BackgroundPaul, R. K., Singh, N. S., Khadeer, M., Moaddel, R., Sanghvi, M., Green, C. E., O’Loughlin, K., Torjman, M. C., Bernier, M., & Wainer, I. W. (2014) · Anesthesiology · doi:10.1097/aln.0000000000000285 · Cited by 115
Reduced platelet BDNF level in patients with major depression
Lee, B.-H., & Kim, Y.-K. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.04.002 · Cited by 109 · cited 1×
“Up‐regulation in BDNF is an appealing consequence of ketamine exposure, given that levels of BDNF are reduced in major depression.(79) We found no evidence of new synapses induced by exposure to ketamine.”
BackgroundStress-Induced Changes of Hippocampal NMDA Receptors: Modulation by Duloxetine Treatment
Calabrese, F., Guidotti, G., Molteni, R., Racagni, G., Mancini, M., & Riva, M. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037916 · Cited by 107
Beurel, E., Grieco, S. F., Amadei, C., Downey, K., & Jope, R. S. (2016) · Bipolar Disorders · doi:10.1111/bdi.12436 · Cited by 76
Pozzi, L., Dorocic, I. P., Wang, X., Carlén, M., & Meletis, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0083879 · Cited by 74 · cited 1×
“However, this is in contrast to studies showing no specific effect of ketamine on fast spiking, parvalbumin‐containing interneurons.(27,28) There are also conflicting results regarding ketamine causing a hyperglutamatergic state(29) or rather a pre‐synaptic NR2B‐dependant decrease in release probability.”
ResultKetamine regulates the presynaptic release machinery in the hippocampus
Müller, H. K., Wegener, G., Liebenberg, N., Zarate, C. A., Popoli, M., & Elfving, B. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.03.008 · Cited by 61
Age dependence of the rapid antidepressant and synaptic effects of acute NMDA receptor blockade
Nosyreva, E., Autry, A. E., Kavalali, E. T., & Monteggia, L. M. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00094 · Cited by 51 · cited 6×
“We used animals of two different ages for most of the experiments and both the dorsal and ventral part of the hippocampus as well as animals of the same sex (males), variables known to influence the efficacy of ketamine and NMDA‐receptor blockade.(20,42,46,47) An increased efficacy of glutamatergic synaptic transmissi…”
BackgroundMethodResultInfluentialRiebe, I., Seth, H., Culley, G., Dósa, Z., Radi, S., Strand, K., Fröjd, V., & Hanse, E. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13128 · Cited by 40 · cited 1×
“Since there is a specific distribution of NMDAR subunits on excitatory pyramidal cells and inhibitory interneurons within the hippocampus, ketamine, in therapeutic concentrations, might act preferentially on interneurons, similar to memantine, another NMDAR antagonist.(104) Despite their difference in NMDAR desensitiz…”
BackgroundSelf-citation
Cited by
Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels
Hansen, K. B., Wollmuth, L. P., Bowie, D., Furukawa, H., Menniti, F. S., Sobolevsky, A. I., Swanson, G. T., Swanger, S. A., Greger, I. H., Nakagawa, T., et al. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000131 · Cited by 686
Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine
Deyama, S., & Duman, R. S. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.172837 · Cited by 186
Aleksandrova, L. R., Wang, Y. T., & Phillips, A. G. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.07.007 · Cited by 114
Hydroxynorketamines: Pharmacology and Potential Therapeutic Applications
Highland, J. N., Zanos, P., Riggs, L. M., Georgiou, P., Clark, S. M., Morris, P. J., Moaddel, R., Thomas, C. J., Zarate, C. A., Pereira, E. F. R., et al. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000149 · Cited by 92
Aleksandrova, L. R., Wang, Y. T., & Phillips, A. G. (2020) · Molecular Brain · doi:10.1186/s13041-020-00627-z · Cited by 85
Metadata
- Authors
- Michaëlsson, H., Andersson, M., Svensson, J., Karlsson, L., Ehn, J., Culley, G., Engström, A., Bergström, N., Savvidi, P., Kuhn, H., Hanse, E., & Seth, H.
- Venue
- Acta Physiologica
- Publisher
- Wiley
- Published
- 2018-11-25
- Volume
- 225
- Issue
- 4
- Pages
- e13211-e13211
- ISSN
- 1748-1708 (ISSN-L)
- 1748-1716
- OpenAlex
- W2896004322
- Cited by
- 28
- References
- 42
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.